These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 26031770)
21. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle. Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Klinge L; Straub V; Neudorf U; Schaper J; Bosbach T; Görlinger K; Wallot M; Richards S; Voit T Neuromuscul Disord; 2005 Jan; 15(1):24-31. PubMed ID: 15639117 [TBL] [Abstract][Full Text] [Related]
23. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258 [TBL] [Abstract][Full Text] [Related]
24. Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Teng YT; Su WJ; Hou JW; Huang SF Chang Gung Med J; 2004 May; 27(5):379-84. PubMed ID: 15366815 [TBL] [Abstract][Full Text] [Related]
25. Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease. Pauly DF; Fraites TJ; Toma C; Bayes HS; Huie ML; Hirschhorn R; Plotz PH; Raben N; Kessler PD; Byrne BJ Hum Gene Ther; 2001 Mar; 12(5):527-38. PubMed ID: 11268285 [TBL] [Abstract][Full Text] [Related]
26. Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. Kikuchi T; Yang HW; Pennybacker M; Ichihara N; Mizutani M; Van Hove JL; Chen YT J Clin Invest; 1998 Feb; 101(4):827-33. PubMed ID: 9466978 [TBL] [Abstract][Full Text] [Related]
27. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid α-glucosidase activity. Bali DS; Tolun AA; Goldstein JL; Dai J; Kishnani PS Muscle Nerve; 2011 May; 43(5):665-70. PubMed ID: 21484825 [TBL] [Abstract][Full Text] [Related]
28. Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Rucker M; Fraites TJ; Porvasnik SL; Lewis MA; Zolotukhin I; Cloutier DA; Byrne BJ Development; 2004 Jun; 131(12):3007-19. PubMed ID: 15169761 [TBL] [Abstract][Full Text] [Related]